Article
Short stature and its treatment in Turner and Noonan syndromes.
Current opinion in endocrinology, diabetes, and obesity - 1 Feb 2012
Chacko Elizabeth M, Rapaport Robert
Abstract excerpt
PURPOSE OF REVIEW: We review recent developments in the approach to the treatment of short stature in patients with Turner and Noonan syndromes. RECENT FINDINGS: Turner syndrome and Noonan syndrome are clinically defined conditions associated with short stature. The Food and Drug Administration (FDA) approved treatment with recombinant human growth hormone (hGH) for patients with Turner syndrome in 1996 and for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
